Winslow Capital Management, LLC Biomarin Pharmaceutical Inc Transaction History

Winslow Capital Management, LLC

  • $27.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$71.87 - $131.03 $161 Million - $294 Million
-2,244,976 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $7.49 Million - $11.7 Million
94,154 Added 4.38%
2,244,976 $277 Million
Q1 2020

May 15, 2020
BUY
$71.37 - $96.85 $154 Million - $208 Million
2,150,822 New
2,150,822 $182 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Winslow Capital Management, LLC Portfolio

Follow Winslow Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email